Cover

Author Jensen, Andrew R.
Nelson, Scott D.
Geiger, Erik J.
Singh, Arun S.
Bernthal, Nicholas M.
Author_xml – sequence: 1
  givenname: Erik J.
  orcidid: 0000-0002-7487-6465
  surname: Geiger
  fullname: Geiger, Erik J.
  email: erik.geiger@rothmanortho.com
  organization: Department of Orthopaedic Surgery, The Rothman Institute at Thomas Jefferson University, Philadelphia, PA, USA
– sequence: 2
  givenname: Andrew R.
  surname: Jensen
  fullname: Jensen, Andrew R.
  organization: Department of Orthopaedic Surgery, University of California-Los Angeles, Santa Monica, CA, USA
– sequence: 3
  givenname: Arun S.
  surname: Singh
  fullname: Singh, Arun S.
  organization: Department of Medicine, Division of Hematology-Oncology, University of California-Los Angeles, Los Angeles, CA, USA
– sequence: 4
  givenname: Scott D.
  surname: Nelson
  fullname: Nelson, Scott D.
  organization: Departments of Pathology and Orthopaedic Surgery, University of California-Los Angeles, Santa Monica, CA, USA
– sequence: 5
  givenname: Nicholas M.
  surname: Bernthal
  fullname: Bernthal, Nicholas M.
  organization: Department of Orthopaedic Surgery, University of California-Los Angeles, Santa Monica, CA, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/36402606$$D View this record in MEDLINE/PubMed
BookMark eNqFkU9vFSEUxYmpsa_VD-DGsHQzT2CYP-iqabQ1aeLGrgkwlycjMzyBefV9e5m8dtNFXd1wcn4nl3su0NkcZkDoPSVbSmj7adyOIW0ZYay8t0V5hTaU121VpPoMbYjgomJt05-ji5RGQmjXiOYNOq9bTlhL2g2K9wlwsHiGoIZxOag54z38dYOK2c1O4weXf2HvJo2T8ge1A5yWuIN4xDZEPDhrl5KQYQ7pOIeDUx7v3JpiwHuclynEz_gKG1VcEfYh5rfotVU-wbvHeYnuv339eX1b3f24-X59dVcZzrpcMWqF7oVglFkjOCeEQ286IsAyMMNgWUOg4_UAXW-1JUprrpk23DaaU03rS_TxlLuP4c8CKcvJpXUrVT67JMm6uqeCCUGK9cOjddETDHIf3aTiUT7dqRi6k8HEkFIEK43LKrsw56icl5TItRE5ytKIXBtZpaIUkj4jn8JfYr6cGCjnOTiIMhkHs4HBRTBZDsG9SItntPGlSqP8bzj-h_0HUuq4tQ
CitedBy_id crossref_primary_10_1007_s40278_024_72908_7
crossref_primary_10_2174_0115733971272967231120114621
crossref_primary_10_1007_s40487_024_00298_z
Cites_doi 10.1073/pnas.0507321103
10.1056/NEJMoa1411366
10.1016/S1470-2045(19)30100-7
10.1007/s11864-015-0385-x
10.1016/j.semarthrit.2010.07.005
10.1016/S1470-2045(15)00132-1
10.1002/cncr.26409
10.1007/s40265-019-01210-0
10.1002/cncr.33312
10.1016/j.clinthera.2016.03.008
10.1186/s13023-021-01820-6
10.1038/s41598-019-51211-y
10.1016/S0140-6736(19)30764-0
10.1016/S1470-2045(18)30143-8
10.1016/j.ejca.2014.11.001
ContentType Journal Article
Copyright 2022 The Japanese Orthopaedic Association
Copyright_xml – notice: 2022 The Japanese Orthopaedic Association
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1016/j.jos.2022.10.016
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 1436-2023
EndPage 462
ExternalDocumentID 36402606
10_1016_j_jos_2022_10_016
S0949265822003049
Genre Journal Article
Case Reports
GroupedDBID ---
-Y2
-~C
.1-
.55
.86
.FO
.VR
06C
06D
07C
0R~
0VY
1N0
1P~
1SB
2.D
28-
29L
2JY
2LR
2P1
2VQ
2~H
30V
4.4
408
409
40D
40E
457
53G
5GY
5QI
5VS
67Z
6NX
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95.
95~
96X
AAEJM
AAIAL
AALRI
AANXM
AARHV
AAWCG
AAWTL
AAXUO
AAYQN
AAYZH
ABBXA
ABFSG
ABJNI
ABMNI
ABQSL
ABTMW
ABUWG
ACBXY
ACGFS
ACOMO
ACSTC
ADBBV
ADHIR
ADHKG
ADIMF
ADKPE
ADRFC
AEFIE
AEGNC
AENEX
AEOHA
AEPYU
AETLH
AEVXI
AEZWR
AFBBN
AFEXP
AFHIU
AFJKZ
AFKRA
AFLOW
AFRHN
AFTJW
AFWTZ
AGGDS
AGJBK
AGQMX
AGQPQ
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHWEU
AIIXL
AITUG
AIXLP
AJBLW
AJJEV
AJUYK
AKMHD
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMRAJ
APXCP
ASPBG
AVWKF
AZFZN
BA0
BBWZM
BELOY
BENPR
BGNMA
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DL5
DU5
EBS
EJD
EMOBN
EN4
ESBYG
EX3
F5P
FDB
FEDTE
FYUFA
G-Y
G-Z
GGRSB
GQ7
GQ8
GXS
H13
HF~
HG5
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IXC
IXE
IZIGR
IZQ
I~X
I~Z
J0Z
JBSCW
JCJTX
KDC
KOV
KOW
KPH
LAS
M1P
M4Y
MA-
N2Q
N9A
NAPCQ
NB0
NDZJH
NU0
O9-
O93
O9G
O9I
OAM
OF0
OR.
P19
P9S
PF0
PHGZM
PHGZT
PJZUB
PPXIY
PQQKQ
PROAC
PSQYO
PT5
PUEGO
Q2X
QOK
QOS
R4E
R89
R9I
RNI
RNS
ROL
RPX
RRX
RSV
RZK
S1Z
S26
S27
S28
S37
S3B
SAP
SDH
SDM
SHX
SMD
SOJ
SV3
T13
T16
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
VC2
W48
WJK
WK8
WOW
X7M
Z45
Z5R
ZOVNA
~A9
~EX
ABTEG
AFCTW
ALIPV
RIG
AAYXX
CITATION
ACRZS
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ID FETCH-LOGICAL-c427t-21f9b899212fc944004e8c709ef2ecddf250e743de78fbf0abb4b2bc4f5b41b13
ISSN 0949-2658
1436-2023
IngestDate Fri Sep 05 04:51:41 EDT 2025
Sat Mar 29 01:29:19 EDT 2025
Wed Oct 01 05:51:03 EDT 2025
Thu Apr 24 22:52:24 EDT 2025
Sat Jul 05 17:10:47 EDT 2025
Tue Aug 26 19:24:33 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords Pexidartinib
Limb salvage
Shoulder arthroplasty
Tenosynovial giant cell tumor (TGCT)
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c427t-21f9b899212fc944004e8c709ef2ecddf250e743de78fbf0abb4b2bc4f5b41b13
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ORCID 0000-0002-7487-6465
PMID 36402606
PQID 2738192990
PQPubID 23479
PageCount 5
ParticipantIDs proquest_miscellaneous_2738192990
pubmed_primary_36402606
crossref_citationtrail_10_1016_j_jos_2022_10_016
crossref_primary_10_1016_j_jos_2022_10_016
elsevier_sciencedirect_doi_10_1016_j_jos_2022_10_016
elsevier_clinicalkey_doi_10_1016_j_jos_2022_10_016
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate January 2024
2024-01-00
20240101
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 01
  year: 2024
  text: January 2024
PublicationDecade 2020
PublicationPlace Japan
PublicationPlace_xml – name: Japan
PublicationTitle Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association
PublicationTitleAlternate J Orthop Sci
PublicationYear 2024
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Ottaviani, Ayral, Dougados, Gossec (bib5) 2011 Jun; 40
Verspoor, Mastboom, Hannink, Maki, Wagner, Bompas (bib9) 2019 Oct 10; 9
Gelderblom, Cropet, Chevreau, Boyle, Tattersall, Stacchiotti (bib10) 2018 May; 19
Tap, Wainberg, Anthony, Ibrahim, Zhang, Healey (bib12) 2015 Jul 30; 373
Cassier, Italiano, Gomez-Roca, Le Tourneau, Toulmonde, Cannarile (bib11) 2015 Aug; 16
Cassier, Gelderblom, Stacchiotti, Thomas, Maki, Kroep (bib8) 2012 Mar 15; 118
Bernthal, Spierenburg, Healey, Palmerini, Bauer, Gelderblom (bib17) 2021 Apr 29; 16
Gelderblom, Wagner, Tap, Palmerini, Wainberg, Desai (bib15) 2021 Mar 15; 127
Mastboom, Verspoor, Gelderblom, van de Sande (bib4) 2017; 2017
Lamb (bib14) 2019 Nov; 79
Gelhorn, Tong, McQuarrie, Vernon, Hanlon, Maclaine (bib16) 2016 Apr; 38
Mastboom, Palmerini, Verspoor, Rueten-Budde, Stacchiotti, Staals (bib2) 2019 Jun; 20
Giustini, Bernthal, Bukata, Singh (bib1) 2018 Jul 10; 8
Tap, Gelderblom, Palmerini, Desai, Bauer, Blay (bib13) 2019 Aug 10; 394
West, Rubin, Miller, Subramanian, Kaygusuz, Montgomery (bib6) 2006 Jan 17; 103
Brahmi, Vinceneux, Cassier (bib7) 2016 Feb; 17
Palmerini, Staals, Maki, Pengo, Cioffi, Gambarotti (bib3) 2015 Jan; 51
Lamb (10.1016/j.jos.2022.10.016_bib14) 2019; 79
Verspoor (10.1016/j.jos.2022.10.016_bib9) 2019; 9
Tap (10.1016/j.jos.2022.10.016_bib12) 2015; 373
West (10.1016/j.jos.2022.10.016_bib6) 2006; 103
Mastboom (10.1016/j.jos.2022.10.016_bib4) 2017; 2017
Cassier (10.1016/j.jos.2022.10.016_bib8) 2012; 118
Gelderblom (10.1016/j.jos.2022.10.016_bib10) 2018; 19
Gelderblom (10.1016/j.jos.2022.10.016_bib15) 2021; 127
Tap (10.1016/j.jos.2022.10.016_bib13) 2019; 394
Ottaviani (10.1016/j.jos.2022.10.016_bib5) 2011; 40
Palmerini (10.1016/j.jos.2022.10.016_bib3) 2015; 51
Giustini (10.1016/j.jos.2022.10.016_bib1) 2018; 8
Gelhorn (10.1016/j.jos.2022.10.016_bib16) 2016; 38
Brahmi (10.1016/j.jos.2022.10.016_bib7) 2016; 17
Mastboom (10.1016/j.jos.2022.10.016_bib2) 2019; 20
Bernthal (10.1016/j.jos.2022.10.016_bib17) 2021; 16
Cassier (10.1016/j.jos.2022.10.016_bib11) 2015; 16
References_xml – volume: 118
  start-page: 1649
  year: 2012 Mar 15
  end-page: 1655
  ident: bib8
  article-title: Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis
  publication-title: Cancer
– volume: 19
  start-page: 639
  year: 2018 May
  end-page: 648
  ident: bib10
  article-title: Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
  publication-title: Lancet Oncol
– volume: 51
  start-page: 210
  year: 2015 Jan
  end-page: 217
  ident: bib3
  article-title: Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors
  publication-title: European journal of cancer (Oxford, England : 1990
– volume: 127
  start-page: 884
  year: 2021 Mar 15
  end-page: 893
  ident: bib15
  article-title: Long-term outcomes of pexidartinib in tenosynovial giant cell tumors
  publication-title: Cancer
– volume: 16
  start-page: 949
  year: 2015 Aug
  end-page: 956
  ident: bib11
  article-title: CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study
  publication-title: Lancet Oncol
– volume: 17
  start-page: 10
  year: 2016 Feb
  ident: bib7
  article-title: Current systemic treatment options for tenosynovial giant cell tumor/pigmented villonodular synovitis: targeting the CSF1/CSF1R Axis
  publication-title: Current treatment options in oncology
– volume: 394
  start-page: 478
  year: 2019 Aug 10
  end-page: 487
  ident: bib13
  article-title: Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
  publication-title: Lancet
– volume: 2017
  start-page: 7402570
  year: 2017
  ident: bib4
  article-title: Limb amputation after multiple treatments of tenosynovial giant cell tumour: series of 4 Dutch cases
  publication-title: Case Rep Orthop
– volume: 79
  start-page: 1805
  year: 2019 Nov
  end-page: 1812
  ident: bib14
  article-title: Pexidartinib: first approval
  publication-title: Drugs
– volume: 9
  start-page: 14551
  year: 2019 Oct 10
  ident: bib9
  article-title: Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor
  publication-title: Sci Rep
– volume: 8
  year: 2018 Jul 10
  ident: bib1
  article-title: Tenosynovial giant cell tumor: case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature
  publication-title: Clin Sarcoma Res
– volume: 103
  start-page: 690
  year: 2006 Jan 17
  end-page: 695
  ident: bib6
  article-title: A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells
  publication-title: Proc Natl Acad Sci U S A
– volume: 20
  start-page: 877
  year: 2019 Jun
  end-page: 886
  ident: bib2
  article-title: Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study
  publication-title: Lancet Oncol
– volume: 38
  start-page: 778
  year: 2016 Apr
  end-page: 793
  ident: bib16
  article-title: Patient-reported symptoms of tenosynovial giant cell tumors
  publication-title: Clin Ther
– volume: 16
  start-page: 191
  year: 2021 Apr 29
  ident: bib17
  article-title: The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study
  publication-title: Orphanet J Rare Dis
– volume: 373
  start-page: 428
  year: 2015 Jul 30
  end-page: 437
  ident: bib12
  article-title: Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor
  publication-title: N Engl J Med
– volume: 40
  start-page: 539
  year: 2011 Jun
  end-page: 546
  ident: bib5
  article-title: Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature
  publication-title: Semin Arthritis Rheum
– volume: 103
  start-page: 690
  issue: 3
  year: 2006
  ident: 10.1016/j.jos.2022.10.016_bib6
  article-title: A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.0507321103
– volume: 373
  start-page: 428
  issue: 5
  year: 2015
  ident: 10.1016/j.jos.2022.10.016_bib12
  article-title: Structure-guided blockade of CSF1R kinase in tenosynovial giant-cell tumor
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa1411366
– volume: 20
  start-page: 877
  issue: 6
  year: 2019
  ident: 10.1016/j.jos.2022.10.016_bib2
  article-title: Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(19)30100-7
– volume: 2017
  start-page: 7402570
  year: 2017
  ident: 10.1016/j.jos.2022.10.016_bib4
  article-title: Limb amputation after multiple treatments of tenosynovial giant cell tumour: series of 4 Dutch cases
  publication-title: Case Rep Orthop
– volume: 17
  start-page: 10
  issue: 2
  year: 2016
  ident: 10.1016/j.jos.2022.10.016_bib7
  article-title: Current systemic treatment options for tenosynovial giant cell tumor/pigmented villonodular synovitis: targeting the CSF1/CSF1R Axis
  publication-title: Current treatment options in oncology
  doi: 10.1007/s11864-015-0385-x
– volume: 40
  start-page: 539
  issue: 6
  year: 2011
  ident: 10.1016/j.jos.2022.10.016_bib5
  article-title: Pigmented villonodular synovitis: a retrospective single-center study of 122 cases and review of the literature
  publication-title: Semin Arthritis Rheum
  doi: 10.1016/j.semarthrit.2010.07.005
– volume: 16
  start-page: 949
  issue: 8
  year: 2015
  ident: 10.1016/j.jos.2022.10.016_bib11
  article-title: CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(15)00132-1
– volume: 8
  issue: 14
  year: 2018
  ident: 10.1016/j.jos.2022.10.016_bib1
  article-title: Tenosynovial giant cell tumor: case report of a patient effectively treated with pexidartinib (PLX3397) and review of the literature
  publication-title: Clin Sarcoma Res
– volume: 118
  start-page: 1649
  issue: 6
  year: 2012
  ident: 10.1016/j.jos.2022.10.016_bib8
  article-title: Efficacy of imatinib mesylate for the treatment of locally advanced and/or metastatic tenosynovial giant cell tumor/pigmented villonodular synovitis
  publication-title: Cancer
  doi: 10.1002/cncr.26409
– volume: 79
  start-page: 1805
  issue: 16
  year: 2019
  ident: 10.1016/j.jos.2022.10.016_bib14
  article-title: Pexidartinib: first approval
  publication-title: Drugs
  doi: 10.1007/s40265-019-01210-0
– volume: 127
  start-page: 884
  issue: 6
  year: 2021
  ident: 10.1016/j.jos.2022.10.016_bib15
  article-title: Long-term outcomes of pexidartinib in tenosynovial giant cell tumors
  publication-title: Cancer
  doi: 10.1002/cncr.33312
– volume: 38
  start-page: 778
  issue: 4
  year: 2016
  ident: 10.1016/j.jos.2022.10.016_bib16
  article-title: Patient-reported symptoms of tenosynovial giant cell tumors
  publication-title: Clin Ther
  doi: 10.1016/j.clinthera.2016.03.008
– volume: 16
  start-page: 191
  issue: 1
  year: 2021
  ident: 10.1016/j.jos.2022.10.016_bib17
  article-title: The diffuse-type tenosynovial giant cell tumor (dt-TGCT) patient journey: a prospective multicenter study
  publication-title: Orphanet J Rare Dis
  doi: 10.1186/s13023-021-01820-6
– volume: 9
  start-page: 14551
  issue: 1
  year: 2019
  ident: 10.1016/j.jos.2022.10.016_bib9
  article-title: Long-term efficacy of imatinib mesylate in patients with advanced Tenosynovial Giant Cell Tumor
  publication-title: Sci Rep
  doi: 10.1038/s41598-019-51211-y
– volume: 394
  start-page: 478
  issue: 10197
  year: 2019
  ident: 10.1016/j.jos.2022.10.016_bib13
  article-title: Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial
  publication-title: Lancet
  doi: 10.1016/S0140-6736(19)30764-0
– volume: 19
  start-page: 639
  issue: 5
  year: 2018
  ident: 10.1016/j.jos.2022.10.016_bib10
  article-title: Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial
  publication-title: Lancet Oncol
  doi: 10.1016/S1470-2045(18)30143-8
– volume: 51
  start-page: 210
  issue: 2
  year: 2015
  ident: 10.1016/j.jos.2022.10.016_bib3
  article-title: Tenosynovial giant cell tumour/pigmented villonodular synovitis: outcome of 294 patients before the era of kinase inhibitors
  publication-title: European journal of cancer (Oxford, England : 1990
  doi: 10.1016/j.ejca.2014.11.001
SSID ssj0017595
Score 2.3681006
SourceID proquest
pubmed
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 458
SubjectTerms Giant Cell Tumor of Tendon Sheath - diagnostic imaging
Giant Cell Tumor of Tendon Sheath - drug therapy
Giant Cell Tumor of Tendon Sheath - surgery
Humans
Limb Salvage
Neoadjuvant Therapy
Pexidartinib
Shoulder arthroplasty
Synovitis, Pigmented Villonodular - surgery
Tenosynovial giant cell tumor (TGCT)
Title Use of neoadjuvant pexidartinib with limb salvage surgery for diffuse tenosynovial giant cell tumor: A case report
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0949265822003049
https://dx.doi.org/10.1016/j.jos.2022.10.016
https://www.ncbi.nlm.nih.gov/pubmed/36402606
https://www.proquest.com/docview/2738192990
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVLSH
  databaseName: SpringerLink Journals
  customDbUrl:
  mediaType: online
  eissn: 1436-2023
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017595
  issn: 0949-2658
  databaseCode: AFBBN
  dateStart: 19970101
  isFulltext: true
  providerName: Library Specific Holdings
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1436-2023
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017595
  issn: 0949-2658
  databaseCode: U2A
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKJqG9IBC3cpOReKJK1ThO0vDWAdNUifKwVdpbZCf2lNImU5dMwL_jn3GO7bRRoePyElVO7FQ5n4-Pz-UzIW-EFjoKWeaNRAAbFD_UngiD3NNBNFYyCSU3TEyfZtHpnE8vwote70cna6mp5TD7_tu6kv-RKrSBXLFK9h8kuxkUGuA3yBeuIGG4_pWM59YRX6pK5IsGbGKkIf5a5IYaoJDWybosVnJwLZY3mJ1zbaugTXIhno3SwAg18oV_K6sbdJ5fFjgKuvMHdbOq1rZyPYO1zoUX9lizGP6B_TeGfQZtqdA-igq0daewSOPhl4PPnY67WMG8IFVcupKcdfFlG8SaqtL5jmxK5jbx8QwWY-MrmqybcuvZnamWl_LM0FF86Po7GO_4O5TV0TyIPDz1vavEndukC1arkbllhv9lpbBOi8VwUSFpO2NDzPGzZZ8d5FytDHSCiCP32g5nt7UC3K075JDFEYf9_-Hk5Ph4tgllxWEStuF0k1i488YjcrcdY59ttG_vY2yg8_vknhM3nVgkPiA9VT4ka0AhrTTtoJB2UUgRhRRRSB0KqUMhBRRSh0LaRSE1KKSIQmpQ-I5OKGKQWgw-IvOTj-fvTz13koeXcRbXHvN1ImFnD3aSzhKO64YaZ_EoUZqpLM81GOIKbNlcxWMt9UhIySWTGdegLHzpB4_JQVmV6imheRgKfyQSf6wCLoUvGKihOArzUI6jIOZ9Mmq_YZo5mns8bWWZtvmMixQkkKIEsAla-uTtpsuV5Xi57WHWCiZti5dhuU0BV7d14ptObg5ai_VP3V63kk9B6-NXh6lZNfBQbJgMwZTskycWEpu_3qLp2d47z8nRdma9IAf1ulEvwbau5SuH3p-6mtSh
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Use+of+neoadjuvant+pexidartinib+with+limb+salvage+surgery+for+diffuse+tenosynovial+giant+cell+tumor%3A+A+case+report&rft.jtitle=Journal+of+orthopaedic+science+%3A+official+journal+of+the+Japanese+Orthopaedic+Association&rft.au=Geiger%2C+Erik+J&rft.au=Jensen%2C+Andrew+R&rft.au=Singh%2C+Arun+S&rft.au=Nelson%2C+Scott+D&rft.date=2024-01-01&rft.eissn=1436-2023&rft.volume=29&rft.issue=1&rft.spage=458&rft_id=info:doi/10.1016%2Fj.jos.2022.10.016&rft_id=info%3Apmid%2F36402606&rft.externalDocID=36402606
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0949-2658&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0949-2658&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0949-2658&client=summon